AGL

Analyst Sentiment

Wall St. Consensus
Hold
23 analysts·High coverage
53
Score
6 Buy (26%)14 Hold (61%)3 Sell (13%)
Rating Breakdown
Strong Buy
00%
Buy
626%
Hold
1461%
Sell
313%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$16.00
-42.5%
Consensus
$24.50
-12.0%
Bull
$33.00
+18.5%
12-Month Target Range23 analysts
$16.00$24.50$33.00
Current $27.85Consensus
Current Price
$27.85
Above Consensus
$3.35

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+4.41%
EPS
FY2028
Rev+10.01%
EPS
FY2029
Rev+8.28%
EPS

Earnings Surprises

Recent Analyst Actions

Apr 9, 2026Deutsche Bank
Agilon Health price target adjusted to $33 from $2 at Deutsche Bank
Target:$33.00
+66.3%from $19.84
Apr 8, 2026Evercore ISI
Agilon Health price target adjusted to $16 at Evercore ISI after reverse split
Target:$16.00
-13.4%from $18.47
Oct 7, 2025Wells Fargo
Agilon Health price target lowered to $1.50 from $5 at Wells Fargo
Target:$1.50
-94.6%from $28.00
Aug 15, 2025Jefferies
Agilon Health price target lowered to $1.10 from $2.40 at Jefferies
Target:$1.10
-96.0%from $27.38
Oct 29, 2024Citigroup
Citi Downgrades agilon health Inc (AGL) to Sell
Target:$2.50
-96.0%from $63.00
Oct 2, 2024Bank of America Securities
Agilon Health downgraded to Underperform from Buy at BofA
Target:$3.00
-96.6%from $88.38
Aug 8, 2024Deutsche Bank
agilon health Inc (AGL) PT Lowered to $4 at Deutsche Bank
Target:$4.00
-97.1%from $140.00
May 29, 2024Robert W. Baird
Agilon Health initiated with a Neutral at Baird
Target:$6.00
-95.8%from $144.00
May 24, 2024Truist Financial
agilon health Inc (AGL) PT Raised to $6.50 at Truist Securities
Target:$6.50
-95.4%from $141.25
Jul 26, 2022Truist Financial
Agilon Health (AGL) Stock: $33 Target And Buy Rating
Target:$33.00
-94.7%from $628.25